John R. Rinker
Impact in
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Peripheral Neuropathies and Disorders
- Neurological Disease Mechanisms and Treatments
- Neurological disorders and treatments
-
- Multiple Sclerosis Research Studies
Papers in
-
- Multiple Sclerosis Research Studies 18
- Neurology 11
- Peripheral Neuropathies and Disorders 5
- Long-Term Effects of COVID-19 2
- Neuroinflammation and Neurodegeneration Mechanisms 2
- Neurological disorders and treatments 2
- Co-authors
- Anne H. Cross (5 shared papers)Kathryn Trinkaus (2 shared papers)Robert T. Naismith (2 shared papers)Laura Piccio (2 shared papers)Ilaria Tassi (1 shared paper)Marina Cella (1 shared paper)Elio Scarpini (1 shared paper)Robert E. Schmidt (1 shared paper)
- Journals
- Neurology (5 papers)Multiple Sclerosis and Related Disorders (3 papers)BMJ Open (2 papers)Contemporary Clinical Trials (2 papers)Frontiers in Neurology (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
John R. Rinker
23 papers receiving 639 citations
Peers
Comparison fields: 5 of 77
- Neurology 210
- Pathology and Forensic Medicine 295
- Neurology 152
- Immunology 209
- Health Informatics 9
Countries citing papers authored by John R. Rinker
This map shows the geographic impact of John R. Rinker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Rinker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Rinker more than expected).
Fields of papers citing papers by John R. Rinker
This network shows the impact of papers produced by John R. Rinker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Rinker. The network helps show where John R. Rinker may publish in the future.
Co-authors
The 25 scholars most cited alongside John R. Rinker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 244 | |
| 2 | 2010 | 87 | |
| 3 | 2006 | 60 | |
| 4 | 2016 | 45 | |
| 5 | 2015 | 36 | |
| 6 | 2007 | 36 | |
| 7 | 2010 | 19 | |
| 8 | The Future of Progressive Multiple Sclerosis Therapies. | 2020 | 18 |
| 9 | 2023 | 15 | |
| 10 | 2020 | 14 | |
| 11 | 2019 | 14 | |
| 12 | 2021 | 11 | |
| 13 | 2015 | 10 | |
| 14 | 2018 | 10 | |
| 15 | 2020 | 8 | |
| 16 | 2014 | 7 | |
| 17 | 2007 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2013 | 4 | |
| 20 | 2024 | 2 |
About John R. Rinker
John R. Rinker is a scholar working on Pathology and Forensic Medicine, Neurology, Oncology, Public Health, Environmental and Occupational Health and Hematology, having authored 23 papers that have together received 654 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (18 papers), Polyomavirus and related diseases (6 papers), Peripheral Neuropathies and Disorders (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Long-Term Effects of COVID-19 (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers) and Neurological disorders and treatments (2 papers). The work is most often cited by research in Neurology (210 citations), Pathology and Forensic Medicine (295 citations), Neurology (152 citations), Immunology (209 citations) and Health Informatics (9 citations). John R. Rinker has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Anne H. Cross, Kathryn Trinkaus, Robert T. Naismith, Laura Piccio, Ilaria Tassi, Marina Cella, Elio Scarpini, Robert E. Schmidt, Paola Panina‐Bordignon and Nadia Passini. Their work appears in journals such as Neurology, Multiple Sclerosis and Related Disorders, BMJ Open, Contemporary Clinical Trials and Frontiers in Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.